Aug 28, 2017 12:00 pm UTC| Business
TEL AVIV, Israel, Aug. 28, 2017 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today...
Aug 28, 2017 12:00 pm UTC| Business
CLEVELAND, Ohio, Aug. 28, 2017 -- Pomerantz LLP and Levi Korsinsky, LLP announce that the United States District Court for the Northern District of Ohio has approved the following announcement of a proposed class...
Professional Diversity Network, Inc. Announces Investor Meetings in China
Aug 28, 2017 12:00 pm UTC| Business
CHICAGO, Aug. 28, 2017 -- Professional Diversity Network, Inc., (NASDAQ:IPDN) (“PDN” or the “Company”), a global developer and operator of online and in-person networks that provides access to networking, training,...
Humanigen Appoints Chief Financial Officer
Aug 28, 2017 12:00 pm UTC| Business
BRISBANE, Calif., Aug. 28, 2017 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has appointed Greg Jester as...
Altisource Portfolio Solutions Schedules a Conference Call to Discuss NRZ Agreements
Aug 28, 2017 11:45 am UTC| Business
LUXEMBOURG, Aug. 28, 2017 -- On Tuesday, August 29, 2017, Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ:ASPS) will host a conference call at 10:00 a.m. EDT to provide an overview of its...
Aug 28, 2017 11:37 am UTC| Business
NEW YORK, Aug. 28, 2017 -- Femab Properties Limited, a Lagos based property development and investment company, announced today that it has signed a financing term sheet of USD$500 million with Milost Global Inc, a New...
aTyr Pharma Announces $45 Million Equity Financing
Aug 28, 2017 11:30 am UTC| Business
SAN DIEGO, Aug. 28, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics, harnessing the Resokine pathway, to treat patients...